Chemokines, chemokine receptors and small-molecule antagonists: recent developments.
about
The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessmentGenomic organization, annotation, and ligand-receptor inferences of chicken chemokines and chemokine receptor genes based on comparative genomics.Regulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26Osteoblast-derived oxysterol is a migration-inducing factor for human breast cancer cellsClinical importance and therapeutic implications of the pivotal CXCL12-CXCR4 (chemokine ligand-receptor) interaction in cancer cell migrationImpaired neuropathic pain responses in mice lacking the chemokine receptor CCR2Identification of a cooperative mechanism involving interleukin-13 and eotaxin-2 in experimental allergic lung inflammationOpposing chemokine gradients control human thymocyte migration in situThe chemokine receptor CCR1 is strongly up-regulated after skin injury but dispensable for wound healing.Deletion of CXCR4 in cardiomyocytes exacerbates cardiac dysfunction following isoproterenol administrationFirst pharmacophore model of CCR3 receptor antagonists and its homology model-assisted, stepwise virtual screening.Discovery of 2-[5-(4-Fluorophenylcarbamoyl)pyridin-2-ylsulfanylmethyl]phenylboronic Acid (SX-517): Noncompetitive Boronic Acid Antagonist of CXCR1 and CXCR2Dipyrimidine amines: a novel class of chemokine receptor type 4 antagonists with high specificity.Chemokines and inflammation in heart disease: adaptive or maladaptive?CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, I kappa B kinase, and nuclear factor-kappa B and induces cell-cell adhesion and aortic smooth muscle cell proliferation.Identification of new participants in the rainbow trout (Oncorhynchus mykiss) oocyte maturation and ovulation processes using cDNA microarraysA potential role for CXCR3 chemokines in the response to ocular HSV infection.Chemokines: role in inflammation and immune surveillance.Lymphocyte trafficking to inflamed skin--molecular mechanisms and implications for therapeutic target molecules.Renaming cytokines: MCP-1, major chemokine in pancreatitisCCR1 antagonists in clinical development.Viral strategies for evading antiviral cellular immune responses of the host.Chemokines: integrators of pain and inflammation.The role of MCP-1-CCR2 ligand-receptor axis in chondrocyte degradation and disease progress in knee osteoarthritis.Role of CXCR4 chemokine receptor blockade using AMD3100 for mobilization of autologous hematopoietic progenitor cells.Monocyte chemoattractant protein-1--a major contributor to the inflammatory process associated with diabetes.Monkeypox virus viral chemokine inhibitor (MPV vCCI), a potent inhibitor of rhesus macrophage inflammatory protein-1Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R)Inhibitors of selectin functions in the treatment of inflammatory skin disorders.Chemokine receptor CXCR4 as a therapeutic target for neuroectodermal tumors.Current status and challenges of cytokine pharmacology.Gender differences in the T-cell profiles of the airways in COPD patients associated with clinical phenotypes.Chemokines and their receptors in the allergic airway inflammatory process.Targeting tumor cell motility as a strategy against invasion and metastasis.Metastasis review: from bench to bedside.Differential expression of interleukin-8 and its receptors in the neuroendocrine and non-neuroendocrine compartments of prostate cancer.Discovery of CNS Penetrant CXCR2 Antagonists for the Potential Treatment of CNS Demyelinating Disorders.Site-directed mutagenesis of CC chemokine receptor 1 reveals the mechanism of action of UCB 35625, a small molecule chemokine receptor antagonist.Transcriptomic analysis of global changes in cytokine expression in mouse spleens following acute Toxoplasma gondii infection.Chemokine signaling specificity: essential role for the N-terminal domain of chemokine receptors.
P2860
Q24323040-82BBEEC0-8E0B-448B-8123-71A541E3DF6CQ24805166-6D920C38-CF6B-47CA-8A9E-C84E4DE825D0Q28072580-0FE7CC51-4A29-4B20-AED1-F0DFE05A92F8Q28195859-1B8B714A-81B2-4A86-BF9C-7D61E7737830Q28302968-96492A50-8DED-48DE-8C0A-AFB12D379943Q28505948-F97A3A1C-94E9-42A9-8A3F-F4BA9499EEC5Q28587850-A79E4909-49C5-4D19-B658-C84526DB8C6CQ30539173-A2196B25-3335-4D5B-BA06-3CCF15EA8F58Q33201642-0BDFEF35-845E-4368-B0BA-1E4C9AC4D634Q33590761-F0F05616-8AB2-428F-BEBA-4A9B343394AFQ33809888-9D38378C-C075-4473-9EEB-B7B971910BEFQ34394197-217D6478-D973-44B7-B819-336DF0C19732Q34414241-0450623C-CCF0-4A66-B8EC-BB5AC02BED0AQ34625604-3B23523B-9142-4CE5-B738-27D04BC4DF42Q34649110-BCD18FB0-7A6B-41E8-9495-A79C80898E17Q35039834-94AE3E77-7DA3-4D8C-A249-71FD35EC8CECQ35158048-B32FCB10-579E-4045-87F8-B8CF2F542333Q35579361-1BABB22B-58C7-44D9-8E04-B123427F42C7Q36150816-535AE4B4-62A9-4F74-8673-8A9A98095FCDQ36164454-D1DD0A7B-0C79-4B46-B9F8-39D4A2BA7AC9Q36196440-D8D346A6-1DA2-4E94-9E16-98CEE5B06C8DQ36276589-41B2415C-2922-48CC-93E0-02806CA8E239Q36285939-892C2F7A-8316-462C-8083-7E14C4769219Q36292749-81909E9E-CF69-4016-8C20-BE1F3CC8211FQ36306163-6A0A7F3F-190D-4C98-8CDD-7007E490E40DQ36687948-5BAFAE6B-E90F-4569-83E6-1781CEB230BFQ36899339-DD39AC92-7983-4A28-8F4D-FA5ADAF9CB02Q37062163-BC287A21-D88F-4F3E-BF49-24511E805B8DQ37116804-A4784404-2CD1-4986-975C-10BC31B5E3B6Q37351199-8B95AFB3-9EDA-45FB-AE61-4417C171F886Q37445966-7E8AD88D-BDF8-49C1-A70D-686A9F1F191AQ37538127-A8FD7B10-73F6-4022-B35F-46CE3A6EA85CQ37721300-D05E382C-CE59-454A-8A43-D851F962B23EQ38097602-F9356433-B528-451D-9143-26C549DA955DQ38237985-F79B12AA-6D09-4BDC-AC1D-69FCAE1ED690Q38586188-58590963-9D51-4422-A646-7AC2E4C40863Q40277352-0A8F000E-7086-4D42-B681-ABE6065DE244Q40467514-9077B63A-5DB0-42C4-815E-BA8F8EA02D53Q40934842-7E9B07C9-C87B-4742-B4C2-BCFA7CE9BF78Q41809935-2E39C08C-8A97-40CB-B71E-5C6361A192E8
P2860
Chemokines, chemokine receptors and small-molecule antagonists: recent developments.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Chemokines, chemokine receptors and small-molecule antagonists: recent developments.
@ast
Chemokines, chemokine receptors and small-molecule antagonists: recent developments.
@en
Chemokines, chemokine receptors and small-molecule antagonists: recent developments.
@nl
type
label
Chemokines, chemokine receptors and small-molecule antagonists: recent developments.
@ast
Chemokines, chemokine receptors and small-molecule antagonists: recent developments.
@en
Chemokines, chemokine receptors and small-molecule antagonists: recent developments.
@nl
prefLabel
Chemokines, chemokine receptors and small-molecule antagonists: recent developments.
@ast
Chemokines, chemokine receptors and small-molecule antagonists: recent developments.
@en
Chemokines, chemokine receptors and small-molecule antagonists: recent developments.
@nl
P1476
Chemokines, chemokine receptors and small-molecule antagonists: recent developments.
@en
P2093
James J Onuffer
Richard Horuk
P304
P356
10.1016/S0165-6147(02)02064-3
P577
2002-10-01T00:00:00Z